Merck M&A chief expects more deal flow as Keytruda patent cliff nears
Merck’s M&A chief said he expects “a lot more deal flow” as the Keytruda patent cliff approaches.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.